Quarterly Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7584308

Concept As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
8,332,000,000 JPY
7,214,000,000 JPY
Interest and dividends received
236,000,000 JPY
217,000,000 JPY
Interest paid
-8,000,000 JPY
-8,000,000 JPY
Net cash provided by (used in) operating activities
6,427,000,000 JPY
5,434,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,114,000,000 JPY
-1,481,000,000 JPY
Proceeds from sale of property, plant and equipment
2,000,000 JPY
704,000,000 JPY
Proceeds from sale of investment securities
5,000,000 JPY
JPY
Other, net
-158,000,000 JPY
-220,000,000 JPY
Net cash provided by (used in) investing activities
-1,410,000,000 JPY
-1,182,000,000 JPY
Cash flows from financing activities
Dividends paid
-2,835,000,000 JPY
-2,874,000,000 JPY
Net cash provided by (used in) financing activities
-4,174,000,000 JPY
-5,287,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
842,000,000 JPY
-1,035,000,000 JPY
Cash and cash equivalents
75,467,000,000 JPY
74,625,000,000 JPY
76,270,000,000 JPY
77,305,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.